These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22565006)

  • 1. Cracking open window of opportunity trials.
    Kalinsky K; Hershman DL
    J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin as an addition to conventional chemotherapy in breast cancer.
    Grenader T; Goldberg A; Shavit L
    J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
    Martin M; Marais R
    J Clin Oncol; 2012 Jul; 30(21):2698-700. PubMed ID: 22565000
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
    Bonanni B; Puntoni M; Cazzaniga M; Pruneri G; Serrano D; Guerrieri-Gonzaga A; Gennari A; Trabacca MS; Galimberti V; Veronesi P; Johansson H; Aristarco V; Bassi F; Luini A; Lazzeroni M; Varricchio C; Viale G; Bruzzi P; Decensi A
    J Clin Oncol; 2012 Jul; 30(21):2593-600. PubMed ID: 22564993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing to fight cancer: the metformin-prostate cancer connection.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin, B(12), and enhanced breast cancer response to chemotherapy.
    Garcia A; Tisman G
    J Clin Oncol; 2010 Jan; 28(2):e19; author reply e20. PubMed ID: 19949002
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.
    Niraula S; Dowling RJ; Ennis M; Chang MC; Done SJ; Hood N; Escallon J; Leong WL; McCready DR; Reedijk M; Stambolic V; Goodwin PJ
    Breast Cancer Res Treat; 2012 Oct; 135(3):821-30. PubMed ID: 22933030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-oncogenic effect of metformin].
    Noto H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathways: preclinical models and clinical trials with metformin in breast cancer.
    Thompson AM
    Clin Cancer Res; 2014 May; 20(10):2508-15. PubMed ID: 24682417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.
    Dowling RJ; Niraula S; Chang MC; Done SJ; Ennis M; McCready DR; Leong WL; Escallon JM; Reedijk M; Goodwin PJ; Stambolic V
    Breast Cancer Res; 2015 Mar; 17(1):32. PubMed ID: 25849721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
    Chandel NS; Avizonis D; Reczek CR; Weinberg SE; Menz S; Neuhaus R; Christian S; Haegebarth A; Algire C; Pollak M
    Cell Metab; 2016 Apr; 23(4):569-70. PubMed ID: 27076070
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
    Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
    Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.
    Lord SR; Patel N; Liu D; Fenwick J; Gleeson F; Buffa F; Harris AL
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):81-6. PubMed ID: 26063894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for cancer prevention.
    Yang Y
    Front Med; 2011 Jun; 5(2):115-7. PubMed ID: 21695613
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin: "Old warrior for a new battle".
    Jain A
    Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin and cancer therapy.
    Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
    Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.